University of Arkansas
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Arkansas sits in the top decile of US sponsors by registered trial count (#113 of 15,742 sponsors by registered trial count).
University of Arkansas: 318 sponsored US clinical trials, 37 recruiting.
University of Arkansas sponsors 318 registered US clinical trials on ClinicalTrials.gov, 37 of them currently recruiting, and 202 completed. 17 of these trials are in Phase 3-4 (later-stage) and 102 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Myeloma, with 15 trials.
Top-decile sponsor footprint
University of Arkansas ranks in the top decile of sponsors by registered trial count (#113 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
202 of 262 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
318 total, page 1 of 7
Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment
NCT07071766
AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
NCT07231627
Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA)
NCT05823727
The HVIP+ Community Model
NCT07539142
How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants
NCT07674953
Growing Healthy Children and Families in Rural Arkansas
NCT06565455
Portable Endoscopic Camera System Using Modified Action Camera for Endoscopic Sinunasal Examination
NCT07289854
Supervision in Substance Use Disorder Treatment Programs
NCT07262372
The Community Garden Health Block
NCT06455215
Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
NCT06923423
Delivering HOPE (Helping Women Optimize Prenatal Equity)
NCT06814509
Residual Gastric Content and GLP-1
NCT06814080
Food Provision in Prenatal Care
NCT06711627
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
NCT06694155
Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids
NCT06560918
Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault
NCT06139354
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
NCT06025292
RFA Using Multi-Tined Electrodes vs.Traditional Electrodes for Lumbar Spondylosis
NCT06477094
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
NCT06313502
Determine the Clinical Effectiveness of Mobile CenteringPregnancy to Improve Maternal and Infant Health Outcomes of Marshallese in Arkansas
NCT07011121
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
NCT06044025
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
NCT05952934
Telehealth Multi-Component Optional Model (MOM) Study
NCT06095960
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
NCT05593484
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
NCT05429892
Universal Basic Income and Structural Racism in the US South: HIV Care
NCT06186128
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NCT05301348
Family Model DSME in FBOs in the RMI
NCT05502016
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
NCT05336188
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
NCT05513833
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
NCT05440760
Exploring the Feasibility of Kōmmour Prenatal to Reduce Maternal and Infant Health Disparities
NCT04558619
Nutritional Therapy for Delirium in Elderly Hospitalized Subjects
NCT05066503
Treatment Outcomes With tDCS in Post-Stroke Aphasia
NCT03929432
Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery
NCT02997293
In Vivo Real-time Detection of Circulating Melanoma Cells
NCT01776905
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
NCT01530373
Barbershop Talk: Reducing Excessive Alcohol Consumption Among Men
NCT05609344
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
NCT05776823
Exploring the Feasibility of Centering Pregnancy With Care Navigation
NCT05645549
Impact of Group Participation on Adults With Aphasia
NCT05520528
Adaptive Implementation to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
NCT05050539
The Human Stress Response in a Simulated ED Setting
NCT04317482
2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
NCT03004287
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738
Mitochondrial Dysfunction in Autism Spectrum Disorder
NCT02000284
Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
NCT01514669
Excision Followed by Radiofrequency Ablation for Breast Cancer
NCT01153035
Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
NCT00871013
UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
NCT00869232
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 62 |
| Phase 3 | 13 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the University of Arkansas pipeline
37 recruiting of 318 indexed (12% open); 202 completed (64%).
Phase mix: 17 late (III/IV) vs 102 early (I/II) (early-phase heavy).
Top condition: Multiple Myeloma (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Arkansas: open-pipeline peers nationwide
Peers matched on 318 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
University of Arkansas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 318 trials (± recruiting share)
- Rush University Medical Center · 320 trials · 17% recruiting
- Jonsson Comprehensive Cancer Center · 321 trials · 19% recruiting
- Allergan · 314 trials · 0% recruiting
- Celgene · 308 trials · 4% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Jazz Pharmaceuticals · 12% recruiting · 128 trials
- Abbott Diabetes Care · 12% recruiting · 26 trials
- Medtronic Vascular · 12% recruiting · 26 trials
- Midwest Center for Metabolic and Cardiovascular Research · 12% recruiting · 26 trials
Related
What to do with this University of Arkansas page
318 registered trials is a research-attention snapshot, not an endorsement of University of Arkansas or any single study.
- 37 of University of Arkansas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Myeloma is the condition University of Arkansas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Myeloma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Arkansas pipeline card: 318 registered trials from official public datasets.Report a data error.